Piper Sandler has recently adjusted its price target for GE HealthCare (GEHC, Financial), reducing it from $104 to $88 while maintaining an Overweight rating on the stock. This revision comes as the firm considers the broader economic and policy uncertainties, which may offer strategic opportunities for investors seeking value buys.
Despite the recent downward pressure on GE HealthCare's stock, Piper Sandler views this decline as potentially excessive. However, the firm acknowledges that the inherent risks associated with GEHC are higher compared to many other large-cap stocks. Furthermore, there is skepticism about whether the upcoming quarterly results and guidance update will significantly alter the current market outlook for GE HealthCare.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 18 analysts, the average target price for GE HealthCare Technologies Inc (GEHC, Financial) is $97.30 with a high estimate of $115.00 and a low estimate of $74.00. The average target implies an upside of 57.83% from the current price of $61.65. More detailed estimate data can be found on the GE HealthCare Technologies Inc (GEHC) Forecast page.
Based on the consensus recommendation from 19 brokerage firms, GE HealthCare Technologies Inc's (GEHC, Financial) average brokerage recommendation is currently 2.1, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
